XWELL Inc (XWEL)
1.73
-0.05
(-2.80%)
USD |
NASDAQ |
May 01, 16:00
1.73
0.00 (0.00%)
After-Hours: 20:00
XWELL Enterprise Value: -7.635M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | -7.635M |
| April 29, 2024 | -7.718M |
| April 26, 2024 | -7.551M |
| April 25, 2024 | -7.551M |
| April 24, 2024 | -7.551M |
| April 23, 2024 | -9.141M |
| April 22, 2024 | -9.433M |
| April 19, 2024 | -9.308M |
| April 18, 2024 | -9.224M |
| April 17, 2024 | -9.266M |
| April 16, 2024 | -9.350M |
| April 15, 2024 | -9.350M |
| April 12, 2024 | -9.146M |
| April 11, 2024 | -8.895M |
| April 10, 2024 | -8.937M |
| April 09, 2024 | -8.686M |
| April 08, 2024 | -8.812M |
| April 05, 2024 | -8.770M |
| April 04, 2024 | -8.616M |
| April 03, 2024 | -8.686M |
| April 02, 2024 | -8.895M |
| April 01, 2024 | -8.101M |
| March 28, 2024 | -8.018M |
| March 27, 2024 | -7.976M |
| March 26, 2024 | -7.892M |
| Date | Value |
|---|---|
| March 25, 2024 | -7.349M |
| March 22, 2024 | -7.307M |
| March 21, 2024 | -7.223M |
| March 20, 2024 | -7.307M |
| March 19, 2024 | -6.513M |
| March 18, 2024 | -7.077M |
| March 15, 2024 | -7.307M |
| March 14, 2024 | -7.349M |
| March 13, 2024 | -6.555M |
| March 12, 2024 | -6.471M |
| March 11, 2024 | -6.722M |
| March 08, 2024 | -6.722M |
| March 07, 2024 | -6.722M |
| March 06, 2024 | -6.722M |
| March 05, 2024 | -6.555M |
| March 04, 2024 | -6.429M |
| March 01, 2024 | -6.617M |
| February 29, 2024 | -6.513M |
| February 28, 2024 | -6.513M |
| February 27, 2024 | -6.513M |
| February 26, 2024 | -6.638M |
| February 23, 2024 | -6.721M |
| February 22, 2024 | -6.646M |
| February 21, 2024 | -6.638M |
| February 20, 2024 | -6.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-15.11M
Minimum
Sep 28 2023
296.15M
Maximum
Jun 22 2020
37.15M
Average
17.37M
Median
Enterprise Value Benchmarks
| Fonar Corp | 41.23M |
| ProPhase Labs Inc | 88.08M |
| Applied DNA Sciences Inc | -0.011M |
| Veracyte Inc | 1.253B |
| OncoCyte Corp | 23.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.584M |
| Revenue (Quarterly) | 7.403M |
| Total Expenses (Quarterly) | 12.03M |
| EPS Diluted (Quarterly) | -1.57 |
| Gross Profit Margin (Quarterly) | 11.86% |
| Profit Margin (Quarterly) | -88.94% |
| Earnings Yield | -390.2% |
| Normalized Earnings Yield | -269.64 |